Genetic Determinants of Response to Beta Blockade.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Atenolol (Primary)
- Indications Coronary artery disease; Heart failure; Hypertension
- Focus Pharmacodynamics; Pharmacogenomic
Most Recent Events
- 30 Nov 2018 Biomarkers information updated
- 03 Jul 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 10 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.